全文获取类型
收费全文 | 16076篇 |
免费 | 788篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 202篇 |
儿科学 | 407篇 |
妇产科学 | 378篇 |
基础医学 | 2114篇 |
口腔科学 | 766篇 |
临床医学 | 1407篇 |
内科学 | 2937篇 |
皮肤病学 | 597篇 |
神经病学 | 1456篇 |
特种医学 | 587篇 |
外国民族医学 | 1篇 |
外科学 | 1910篇 |
综合类 | 78篇 |
一般理论 | 9篇 |
预防医学 | 1580篇 |
眼科学 | 281篇 |
药学 | 1128篇 |
中国医学 | 63篇 |
肿瘤学 | 1004篇 |
出版年
2023年 | 80篇 |
2022年 | 102篇 |
2021年 | 252篇 |
2020年 | 203篇 |
2019年 | 250篇 |
2018年 | 374篇 |
2017年 | 275篇 |
2016年 | 367篇 |
2015年 | 459篇 |
2014年 | 529篇 |
2013年 | 675篇 |
2012年 | 1037篇 |
2011年 | 1251篇 |
2010年 | 663篇 |
2009年 | 516篇 |
2008年 | 880篇 |
2007年 | 972篇 |
2006年 | 947篇 |
2005年 | 849篇 |
2004年 | 787篇 |
2003年 | 665篇 |
2002年 | 713篇 |
2001年 | 321篇 |
2000年 | 342篇 |
1999年 | 336篇 |
1998年 | 134篇 |
1997年 | 116篇 |
1996年 | 87篇 |
1995年 | 74篇 |
1994年 | 71篇 |
1993年 | 64篇 |
1992年 | 132篇 |
1991年 | 128篇 |
1990年 | 120篇 |
1989年 | 131篇 |
1988年 | 100篇 |
1987年 | 103篇 |
1986年 | 112篇 |
1985年 | 89篇 |
1984年 | 63篇 |
1983年 | 64篇 |
1979年 | 86篇 |
1975年 | 66篇 |
1974年 | 77篇 |
1973年 | 71篇 |
1972年 | 75篇 |
1971年 | 70篇 |
1969年 | 75篇 |
1968年 | 62篇 |
1967年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 828 毫秒
81.
82.
Autoimmune haemolytic anaemias. V. Studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease 总被引:2,自引:1,他引:2
下载免费PDF全文
![点击此处可从《Clinical and experimental immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
C. P. Engelfriet A. E. G. Kr. Von Dem Borne Do Beckers E. Reynierse J. J. Van Loghem 《Clinical and experimental immunology》1972,11(2):255-264
Experiments are described the results of which sustain the hypothesis that resistance against complement haemolysis, which is a characteristic of the red cells of patients with chronic cold agglutinin disease, is due to the following mechanism: when red cells react with cold auto-agglutinins in vivo, they are either haemolysed immediately, or, due to an unknown factor, escape direct haemolysis. In the latter case β1E and β1A disappear from the cell membrane. To the sites where these proteins have been attached once, no new β1E or β1A molecules can be bound. Full complement activation thus becomes impossible. 相似文献
83.
Sawyer JR Husain M Lukacs JL Stangeby C Binz RL Al-Mefty O 《Cancer Genetics and Cytogenetics》2003,145(1):38-48
Characteristic cytogenetic aberrations are found in the various histopathological designations of meningioma. These aberrations range from the loss of 22q in histologically benign tumors to complex hypodiploid karyotypes in atypical and malignant tumors. This progression is characterized by increasing chromosome loss and instability, with a critical step being the loss of 1p. We report a detailed cytogenetic investigation of chromosome aberrations in a series of 88 meningiomas using Giemsa banding and multicolor spectral karyotyping (SKY). Clonal chromosome aberrations were identified in 46 (52%) tumors by G banding. Thirty-five tumors showing complex chromosome aberrations not fully characterized by G banding were subsequently reanalyzed by SKY. The SKY technique refined the G-band findings in 18 (51%) of the tumors on which it was applied. The most common features of cytogenetic progression in the complex karyotypes were chromosome arm-specific losses relating to the formation of deletions and dicentric chromosomes involving 1p. Part or all of 1p was lost in 19 tumors. Five tumors showed evidence for the loss of 1p in a progressive step-wise series of telomeric fusions involving the formation of unstable intermediates. Five recurring dicentric chromosomes were identified, including dic (1;11)(p11;p11), dic(1;12)(p12 approximately p13;p11), dic(1;22)(p11;q12 approximately q13), dic(7;19)(p11;p11), and dic(19;22)(p11 approximately p13;q11 approximately q13). These findings provide evidence that telomeric fusions play a role in the formation of clonal deletions, dicentrics, and unbalanced translocations of 1p. The loss of 1p has possible diagnostic and prognostic implications in the management of meningioma. 相似文献
84.
Sturm G Kränke B Rudolph C Aberer W 《The Journal of allergy and clinical immunology》2002,110(6):928-933
BACKGROUND: Hymenoptera venom immunotherapy in allergic patients is a well-established treatment modality for the prevention of systemic anaphylactic reactions caused by insect stings. A variety of therapy regimens exists, from conventional to rush and ultrarush modalities that operate on continuous or intermittent schedules. OBJECTIVE: The aim of this study was to report the 8-year experience with our rush venom immunotherapy regimen in predominantly high-risk patients and to compare data on safety and convenience with the results of 26 studies published from 1978 to 2001. METHODS: One hundred one patients allergic to bee, yellow jacket, or hornet venom were treated with rush Hymenoptera venom immunotherapy. Diagnosis and selection of patients for venom immunotherapy were carried out according to the recommendations of the European Academy of Allergology and Clinical Immunology. We used a 4-day regimen, and the incidence and nature of systemic reactions (SRs) were documented. Fifty-two patients were treated with honeybee venom, and 49 were treated with yellow jacket venom. RESULTS: One hundred (99%) patients reached the maintenance dose. We observed 8 injection-related SRs (0.47% of all injections given) in 7 (6.9%) patients. The number of SRs was higher in patients treated with bee venom extract (12%) compared with in patients receiving yellow jacket venom extract (2%). There was no significant difference in the risk of SRs between female and male patients. The incidence of SRs was considerably lower than the average of 17.8% reported in the literature. CONCLUSION: With a rush immunotherapy regimen over a time period of 8 years in predominantly high-risk patients, the incidence of SRs was low, despite the high number of patients with bee venom allergy, who are more likely to have side effects. Epinephrine as rescue medication was never necessary, and the regimen proved to be safe and convenient for both the patients and the medical staff. 相似文献
85.
Comparison of Track XI fluorometric immunoassay with Bio-EnzaBead enzyme-linked immunosorbent assay for detection of serum antibody to mouse hepatitis virus.
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M C La Regina J Lonigro L Woods W C Hall R E Doyle 《Journal of clinical microbiology》1988,26(3):573-575
The Track XI system (Microbiological Associates, Bethesda, Md.) was compared with the Bio-EnzaBead assay (Organon Teknika, Durham, N.C.) for the detection of antibody to mouse hepatitis virus (MHV). Strain A/J mice were inoculated intranasally with MHV type 3. Sera were collected at 1, 2, 4, and 9 weeks postinoculation and tested. Individual serum samples were retested twice by each method. The results suggested that the Track XI system was more sensitive and reliable than the Bio-EnzaBead assay in detecting antibody to MHV type 3 in individual serum samples from A/J mice. 相似文献
86.
Messer RL Lockwood PE Tseng WY Edwards K Shaw M Caughman GB Lewis JB Wataha JC 《Journal of biomedical materials research. Part B, Applied biomaterials》2005,75(2):257-263
The perennial controversy about the safety of mercury in dental amalgams has adversely affected the availability and the quality of dental care. Chronic Hg(II) blood concentrations above 300 nM are known to alter function of the nervous system and the kidney. However, the effects of blood concentrations of 10 to 75 nM, far more common in the general population, are not clear and mechanisms of any effects are not known. The monocyte is an important potential target of Hg(II) because of its critical role in directing inflammatory and immune responses. In the current study we tested the hypothesis that concentrations of Hg(II) of 10 to 300 nM alter monocyte activity via a redox-dependent mechanism. Mitochondrial activity was used to establish inhibitory concentrations of Hg(II) following 6 to 72 h of exposures to THP1 human monocytic cells. Then subinhibitory concentrations were applied, and total glutathione levels and reactive oxygen species (ROS) were measured. Antioxidants [N-acetyl cysteine, (NAC); Na2SeO3, (Se)] and a pro-oxidant (tert-butylhydroquinone, tBHQ) were used to support the hypothesis that Hg(II) effects were redox-mediated. After 72 h of exposure, 20 microM of Hg(II) inhibited monocytic mitochondrial activity by 50%. NAC mitigated Hg(II)-induced mitochondrial suppression only at concentrations of greater than 10 microM, but Se had few effects on Hg-induced mitochondrial responses. tBHQ significantly enhanced mitochondrial suppression at higher Hg(II) concentrations. Hg(II) concentrations of 75 and 300 nM (0.075 and 0.30 microM, respectively) significantly increased total glutathione levels, and NAC mitigated these increases. Se plus Hg(II) significantly elevated Hg-induced total cellular glutathione levels. Increased ROS levels were not detected in monocytes exposed to mercury. Hg(II) acts in monocytic cells, at least in part, through redox-mediated mechanisms at concentrations below those commonly associated with chronic mercury toxicity, but commonly occurring in the blood of some dental patients. 相似文献
87.
Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Fachado A Rodriguez A Molina J Silvério JC Marino AP Pinto LM Angel SO Infante JF Traub-Cseko Y Amendoeira RR Lannes-Vieira J 《Infection and immunity》2003,71(9):5407-5411
Immunization of BALB/c mice with an expression genomic library of Toxoplasma gondii induces a Th1-type immune response, with recognition of several T. gondii proteins (21 to 117 kDa) and long-term protective immunity against a lethal challenge. These results support further investigations to achieve a multicomponent anti-T. gondii DNA vaccine. 相似文献
88.
Horstkamp BS Kiess H Krämer J Riess H Henrich W Dudenhausen JW 《Human reproduction (Oxford, England)》1999,14(12):3112-3115
A common mutation in the factor V gene, the Leiden mutation, is the most frequent genetic cause of resistance to activated protein C (APC). Recent studies have shown that the prevalence of APC resistance is associated with severe pregnancy-induced hypertension (PIH). Our objective was to determine whether the factor V Leiden mutation is more prevalent in patients who developed severe PIH than in normotensive pregnant women. In 70 women with a history of severe PIH, of whom 15 had pre-eclampsia, we investigated common coagulation factors as well as APC resistance (factor V related). We found that seven of these 70 women showed low values for APC. Out of these, five were heterozygous and none was homozygous for factor V Leiden mutation. In a control group of normotensive pregnant women we found a 3.0% rate of APC resistance and a 3.0% rate of carriers of the Leiden mutation. These results indicate a significantly higher prevalence of both APC resistance and factor V Leiden mutation in women with severe PIH. Placental infarctions and micro-embolisms are considered to be one of the principle pathophysiological changes in severe PIH. Our results suggest that APC resistance is a risk factor for severe PIH, in addition to its well-known role in macrothrombo-embolism. 相似文献
89.
Human papillomavirus type 16 DNA sequence 总被引:159,自引:1,他引:159
Klaus Seedorf Günter Krämmer Matthias Dürst Sandor Suhai Walter G. Röwekamp 《Virology》1985,145(1):181-185
The complete nucleotide sequence of HPV16 DNA (7904 bp) cloned from an invasive cervical carcinoma was determined. Homology comparisons allowed us to align the major open reading frames with the other published papilloma virus DNA sequences. The general organization of the open reading frames is similar to that of the other four papillomavirus (BPV1, HPV1a, HPV6b, CRPV) already sequenced. The sequence reveals an interruption of the reading frame coding for a suspected E1 protein. 相似文献
90.
Effect of low-frequency repetitive transcranial magnetic stimulation on interhemispheric inhibition 总被引:5,自引:0,他引:5
Pal PK Hanajima R Gunraj CA Li JY Wagle-Shukla A Morgante F Chen R 《Journal of neurophysiology》2005,94(3):1668-1675
We studied the effects of 1-Hz repetitive transcranial magnetic stimulation (rTMS) on the excitability of interhemispheric connections in 13 right-handed healthy volunteers. TMS was performed using figure-eight coils, and surface electromyography (EMG) was recorded from both first dorsal interosseous (FDI) muscles. A paired-pulse method with a conditioning stimulus (CS) to the motor cortex (M1) followed by a test stimulus to the opposite M1 was used to study the interhemispheric inhibition (ppIHI). Both CS and TS were adjusted to produce motor-evoked potentials of approximately 1 mV in the contralateral FDI muscles. After baseline measurement of right-to-left IHI (pre-RIHI) and left-to-right IHI (pre-LIHI), rTMS was applied over left M1 at 1 Hz with 900 stimuli at 115% of resting motor threshold. After rTMS, ppIHI was studied using both the pre-rTMS CS (post-RIHI and post-LIHI) and an adjusted post-rTMS CS set to produce 1-mV motor evoked potentials (MEPs; post-RIHI(adj) and post-LIHI(adj)). The TS was set to produce 1-mV MEPs. There was a significant reduction in post-LIHI (P = 0.0049) and post-LIHI(adj) (P = 0.0169) compared with pre-LIHI at both interstimulus intervals of 10 and 40 ms. Post-RIHI was significantly reduced compared with pre-RIHI (P = 0.0015) but pre-RIHI and post-RIHI(adj) were not significantly different. We conclude that 1-Hz rTMS reduces IHI in both directions but is predominantly from the stimulated to the unstimulated hemisphere. Low-frequency rTMS may be used to modulate the excitability of IHI circuits. Treatment protocols using low-frequency rTMS to reduce cortical excitability in neurological and psychiatric conditions need to take into account their effects on IHI. 相似文献